Symbiotec Pharmalab Ipo News

Symbiotec Pharmalab shares listed at a 1% discount on the BSE at ₹978.20, while debuting flat at ₹988 on the NSE.

Symbiotec Pharmalab is set for its IPO listing today, with analysts predicting a potential 20-22% increase based on the latest grey market premium signals.

Symbiotec Pharmalab's IPO, which was oversubscribed 73.63 times by non-institutional investors, is set to list tomorrow, with its grey market premium indicating

The allotment for Symbiotec Pharmalab IPO will be finalized today, with its shares commanding a strong grey market premium (GMP) of ₹270, according to Investorg

Symbiotec Pharmalab IPO has been subscribed 8.78 times by Day 4, with allotment expected on August 28 and listing on September 1 on both BSE and NSE. The articl

The Symbiotec Pharmalab IPO is on its final bidding day with an overall subscription of 5.31 times and a Grey Market Premium (GMP) of Rs 285, indicating a 29% p

Symbiotec Pharmalab IPO is on Day 2 with 80% subscription and a 34% GMP, indicating strong listing expectations, though premium valuations warrant careful consi

Symbiotec Pharmalab IPO's Grey Market Premium (GMP) is currently ₹411, according to market observers.

Symbiotec Pharmalab is launching its IPO from August 24 to August 27, aiming to raise ₹1,757 crore with a price band of ₹938–₹988 per share and a minimum retail

The Symbiotec Pharmalab IPO has set its price band between ₹938 and ₹999 per share, with subscriptions opening on August 24 and closing on August 27, and listin